BATTAGLIA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 474
EU - Europa 202
AS - Asia 12
AF - Africa 1
Totale 689
Nazione #
US - Stati Uniti d'America 473
IT - Italia 118
DE - Germania 29
GB - Regno Unito 13
IE - Irlanda 7
AT - Austria 6
CN - Cina 6
BE - Belgio 5
FI - Finlandia 5
SE - Svezia 5
IN - India 4
FR - Francia 3
NL - Olanda 3
RO - Romania 3
RU - Federazione Russa 3
HK - Hong Kong 2
CA - Canada 1
CH - Svizzera 1
GR - Grecia 1
NG - Nigeria 1
Totale 689
Città #
Chandler 88
Fairfield 61
Ashburn 59
Palermo 31
Altamura 20
Wilmington 19
Woodbridge 19
Seattle 18
Houston 17
Medford 16
New York 16
Cambridge 13
Lawrence 10
Princeton 10
Bremen 9
London 8
Dublin 7
San Diego 7
Ann Arbor 6
Beijing 6
Vienna 6
Brussels 5
Ludwigshafen am Rhein 5
Cagliari 4
Des Moines 4
Helsinki 4
Venice 4
Fasano 3
Messina 3
Pune 3
Afragola 2
Aragona 2
Central 2
Cologne 2
Erice 2
Hamburg 2
Hanover 2
Leawood 2
Milan 2
Misterbianco 2
Novellara 2
Pavia 2
Rieti 2
Rome 2
Tusa 2
Aachen 1
Acquedolci 1
Barcellona Pozzo di Gotto 1
Boardman 1
Boydton 1
Campobasso 1
Catania 1
Clearwater 1
Florence 1
Fremont 1
Islington 1
Isola delle Femmine 1
Kemerovo 1
Kilburn 1
Lappeenranta 1
Mehlingen 1
Mendicino 1
Mogliano 1
Mumbai 1
Napoli 1
New Bedfont 1
Redmond 1
Richmond 1
Saint Petersburg 1
San Francisco 1
Toronto 1
Utrecht 1
Washington 1
Totale 539
Nome #
Optimizing sequential systemic therapies for advanced hepatocellular carcinoma: A decision analysis 109
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 108
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma 82
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 63
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? 62
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals 51
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials 45
Systemic therapies for hepatocellular carcinoma: The present and the future 44
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 43
Consequences of Extended Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients 40
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices 37
Reply 23
Advances in survival analysis: applications and extensions of the "standard" competing risks model 22
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 21
Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data 19
Reply 17
Reply 8
Totale 794
Categoria #
all - tutte 4.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 11 0 16 4 26 13 24 6 20 21
2021/2022194 30 18 9 10 2 7 8 43 26 7 11 23
2022/2023310 20 49 5 37 34 38 29 19 52 9 9 9
2023/2024149 16 22 17 11 9 38 18 10 8 0 0 0
Totale 794